2019
DOI: 10.1038/s41569-019-0266-2
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology of inherited arrhythmias

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
32
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 40 publications
(34 citation statements)
references
References 162 publications
0
32
0
2
Order By: Relevance
“…In humans, the prevalence of J-waves in ECGs varies between 5% and 19% (Offerhaus, Bezzina and Wilde, 2020). In the majority of cases these J-waves are benign.…”
Section: Discussionmentioning
confidence: 99%
“…In humans, the prevalence of J-waves in ECGs varies between 5% and 19% (Offerhaus, Bezzina and Wilde, 2020). In the majority of cases these J-waves are benign.…”
Section: Discussionmentioning
confidence: 99%
“…Founder mutations are mutations shared by a (large) number of individuals who have a common origin and all share a unique chromosomal background (haplotype) on which the mutation occurred. They appear to be frequent in the Netherlands, both in the cardiovascular domain [4][5][6][7][8][9], and in other domains [10]. Within the cardiovascular domain well-studied examples are HCM with three founder mutations being responsible for an estimated 40% of Dutch HCM patients [4,11], the 1795insD mutation in the cardiac sodium channel (SCN5A) associated with a SCN5Aoverlap syndrome (i.e., a disease entity with both gain of function (LQTS) and loss of function characteristics (progressive cardiac conduction disease and Brugada syndrome)) [7], a haplotype on chromosome 7 associated with idiopathic ventricular fibrillation [6], and the PLN Argdel14 mutation [8].…”
Section: Founder Mutationsmentioning
confidence: 99%
“…As a result, the normal physiological functioning of these channels is altered, which disturbs the ionic homeostasis inside the cardiomyocytes (CMs) and affects the cardiac action potential (AP). Hence, an arrhythmogenic substrate arises which increases the risk of life-threatening arrhythmias and consequent sudden cardiac death, even in prior asymptomatic young patients [1,2]. Long QT syndrome (LQTS), short QT syndrome (SQTS), Brugada syndrome (BrS) and catecholaminergic polymorphic Hearts 2020, 1 182 ventricular tachycardia (CPVT) are the four major channelopathies.…”
Section: Introductionmentioning
confidence: 99%
“…Long QT syndrome (LQTS), short QT syndrome (SQTS), Brugada syndrome (BrS) and catecholaminergic polymorphic Hearts 2020, 1 182 ventricular tachycardia (CPVT) are the four major channelopathies. The reported prevalence of channelopathies is often an underestimation because of the presence of asymptomatic mutation carriers, low penetrance, variable expressivity within and between families and diagnostic difficulties as changes in electrocardiogram (ECG) patterns are transient [1][2][3]. Due to this, elucidating the pathophysiological mechanisms behind the ICAs and identifying patients remains challenging.…”
Section: Introductionmentioning
confidence: 99%